Blood monocyte concentration is critical for enhancement of collateral artery growth

American Journal of Physiology - Heart and Circulatory Physiology - Tập 283 Số 6 - Trang H2411-H2419 - 2002
Matthias Heil1, Tibor Ziegelhoeffer1, Frederic Pipp1, Sawa Kostin1, Sandra Martin1, Matthias Clauss1, Wolfgang Schäper1
1Department for Experimental Cardiology, Max Planck Institute for Physiological and Clinical Research, 61231 Bad Nauheim, Germany.

Tóm tắt

0.1152/ajpheart. 01098.2001.—Arteriogenesis has been associated with the presence of monocytes/macrophages within the collateral vessel wall. We tested the hypothesis that arteriogenesis is functionally linked to the concentration of circulating blood monocytes. Monocyte concentrations in peripheral blood were manipulated by single injections of the antimetabolite 5-fluorouracil (5-FU), resulting in a marked rebound effect in New Zealand White rabbits. Collateral artery growth was assessed by the use of a model of acute femoral artery ligation. Seven days after ligation, collateral conductance and the number of visible collateral arteries were increased in the rebound group. This increase was accompanied by an increased monocyte accumulation as demonstrated by immunohistology in the thigh 3 days after surgery. In a second animal model (129S2/SvHsd mice), 5-FU treatment caused a remarkable decrease in blood monocyte numbers at day 4, followed by a rebound effect at day 12. Foot blood flow, assessed by laser-Doppler imaging before and at various time points after surgery, increased from day 7 through day 21 in mice from the rebound group. In contrast, ligation during the phase of monocyte depletion resulted in a reduction of blood flow reconstitution. This inhibition could be reversed by an injection of isolated monocytes. In conclusion, we have demonstrated a functional link between the monocyte concentration in the peripheral blood and the enhancement of arteriogenesis.

Từ khóa


Tài liệu tham khảo

10.1172/JCI119877

10.1161/01.RES.85.3.221

10.1126/science.275.5302.964

10.1093/emboj/18.14.3964

10.1038/87904

Elsaesser H, 2000, J Mol Cell Cardiol, 32, A29

10.1161/01.CIR.100.19.1945

10.1172/JCI119346

10.1161/01.CIR.83.3.739

10.1016/0002-8703(89)90771-0

10.1074/jbc.R000004200

10.1078/0171-9335-00113

10.1016/S0008-6363(00)00243-1

10.1152/ajpheart.1997.273.3.H1255

10.1161/01.RES.80.6.829

Kar R, 1986, Cancer Res, 46, 4491

10.1161/01.CIR.103.5.634

10.1161/hh0901.089986

Longland CJ., 1953, Ann R Coll Surg Engl, 13, 161

Malik N, 1996, J Immunol, 156, 3952

10.1046/j.1365-2141.1997.2583074.x

Peichev M, 2000, Blood, 95, 952, 10.1182/blood.V95.3.952.003k27_952_958

10.1111/j.1365-2141.1979.tb03761.x

10.1038/386671a0

10.1161/01.CIR.85.3.1197

10.1007/BF00427580

10.1161/01.RES.79.5.911

10.1172/JCI9087

10.1002/stem.160144

10.1016/S0008-6363(00)00270-4

10.1007/s004280050039

10.1161/hc4201.097835

Shi Q, 1998, Blood, 92, 362, 10.1182/blood.V92.2.362

10.1161/hc2301.092122

10.1161/01.CIR.103.6.897

10.3109/02841869509093964

10.1161/01.ATV.6.6.601

10.1080/110241599750006929

10.1006/jmcc.1998.0790

10.1161/01.HYP.9.2.122